Loading clinical trials...
Loading clinical trials...
This study is designed as a prospective, non-randomized, observational, multicenter clinical trial. The primary aim of this study is to observe if the use of the rapid responds electroencephalography (EEG) system impacts physician decision making. Secondary aims include exploring the safety and performance information of the Ceribell EEG system compared to conventional EEG system. The study will recruit physicians (Faculty physicians and Trainees) at up to five institutions and examine the impact of rapid response EEG when providing care to patients in whom EEG recording has been ordered for clinical reasons.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of California Los Angeles
Los Angeles, California, United States
Rush University Medical Center Pob
Chicago, Illinois, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Start Date
April 30, 2018
Primary Completion Date
April 30, 2019
Completion Date
July 31, 2019
Last Updated
August 20, 2019
164
ACTUAL participants
Ceribell Rapid Response EEG, Survey
DEVICE
Lead Sponsor
Ceribell Inc.
NCT05077904
NCT05667142
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07234695